Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA animal data efficacy rule

This article was originally published in The Tan Sheet

Executive Summary

Drugs may be approved for human use based solely on animal data in cases where human testing is not feasible or ethical, according to FDA final rule published in May 31 Federal Register. Under the reg, drugs used "to reduce or prevent the toxicity of chemical, biological, radiological or nuclear substances" may be approved for marketing "based on evidence of effectiveness derived only from appropriate animal studies and any additional supporting data," agency says. Reg is part of FDA's effort to help improve nation's ability to respond to emergencies, including terrorist events; notice comes shortly after Congress passed bioterrorism bill (1"The Tan Sheet" May 27, 2002, p. 18)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel